Previous Article | Next Article ![]()
Molecular and Cellular Biology, August 1999, p. 5326-5338, Vol. 19, No. 8
Department of Molecular and Cellular Biology,
Roswell Park Cancer Institute, Buffalo, New York 14263
Received 14 December 1998/Returned for modification 29 April
1999/Accepted 10 May 1999
One of the major actions of interleukin-6 (IL-6) is the
transcriptional activation of acute-phase plasma proteins (APP) genes in liver cells. Signaling by the IL-6 receptor is mediated through the
signal transducing subunit gp130 and involves the activation of
Janus-associated kinases (JAKs), signal transducer and activator of
transcription 3 (STAT3), and mitogen-activated protein (MAP) kinase.
Functional analysis of gp130 in rat hepatoma cells by using transduced
chimeric G-CSFR-gp130 receptor constructs demonstrates that SHP-2, the
Src homology 2 (SH2) domain-containing protein tyrosine phosphatase,
acts as a negative regulator of the JAK/STAT signaling in part by
downregulating JAK activity, thereby indirectly moderating the
induction of STAT3-dependent APP genes. This study shows that in
hepatoma cells, the recruitment and tyrosine phosphorylation of SHP-2,
but not SHC, is the primary signaling event associated with the
activation of MAP kinases (ERK1/2) by gp130. Overexpression of
truncated SHP-2 that lacks Grb2-interacting sites, but not the
full-length catalytically inactive SHP-2, reduces ERK activation by
IL-6, confirming the signal-mediating role of SHP-2. Activation of
ERK1/2 is correlated with induction of the immediate-early response
genes. Stimulation of the c-fos, c-jun, and
egr-1 genes is essentially absent in cells expressing gp130
with a Y759F mutation, which is unable to recruit SHP-2. Interestingly,
both JAK/STAT and SHP-2 pathways regulate the induction of the
junB gene. Moreover, disengagement of SHP-2 from gp130
signaling not only enhances APP gene induction but also further reduces
cell proliferation, in part correlated with the attenuated expression
of immediate-early response genes. These results suggest that IL-6
regulation of APP genes is affected by SHP-2 in two ways: SHP-2 acts as
a phosphatase on the JAK/STAT pathway and serves as linker to the MAP
kinase pathway, which in turn moderates APP production.
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Dual Signaling Role of the Protein Tyrosine
Phosphatase SHP-2 in Regulating Expression of Acute-Phase Plasma
Proteins by Interleukin-6 Cytokine Receptors in Hepatic Cells
*
Corresponding author. Mailing address: Department of
Molecular and Cellular Biology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263. Phone: (716) 845-4587. Fax: (716)
845-8389. E-mail: Baumann{at}sc3101.med.buffalo.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|